Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perindopril orodispersible in early Duchenne muscular dystrophy
2008-003856-32Phase 3Completed
- Sponsor
- Servier
- Start
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Duchenne muscular dystrophy (DMD) comparing Perindopril with Placebo (2 arms). Primary endpoint: Peripheral muscle function (walking perimeter). Started Aug 2008; status: completed.
02
Drugs
perindopril
03
Conditions
Duchenne muscular dystrophy (DMD)
Beyond the preview
Go deeper on 2008-003856-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003856-32.